
CAS Name: N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide monohydrate
Additional Names: 1-bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin monohydrate; bis(2-chlo...
Literature References: Oxazaphosphine cytostatic agent; supresses B-cell activity and antibody formation. Prepn: H. Arnold, F. Bourseaux, Angew. Chem. 70, 539 (1958). Optical resolution study: T. Kawashima et al., J. Org. Chem. 43, 1111 (1978). Toxicology: A. G. Wheeler et al., Toxicol. Appl. Pharmacol. 4, 324 (1962). Book: D. L. Hill, A Review of Cyclophosphamide (Charles C Thomas, Springfield, 1975) 340 pp. Reviews of carcinogenicity studies: IARC Monographs 9, 135-156 (1975); of field trials as defleecing agent for sheep: M. H. Fahmy, Y. Moride, Anim. Breed. Abstr. 52, 7-19 (1984); of clinical toxicology: L. H. Fraiser et al., Drugs 42, 781-795 (1991); of mechanism of action and clinical use: O. M. Colvin, Curr. Pharmaceut. Design 5, 555-560 (1999); of analytical methods: M. Malet-Martino et al., ibid. 561-586; and metabolism: F. Baumann, R. Preiss, J. Chromatogr. B 764, 173-192 (2001).
CAS Name: 9-[(2S,3R,6E)-3-Hydroxy-6-(2-hydroxyethylidene)-2-methyl-2-oxepanyl]-2,6-dimethyl-2-nonen-5-one
Percent Composition: C 70.97%, H 10.12%, O 18.91%
Literature References: Oxepane diterpenoid isolated from the leaves of the zoapatle plant, Montanoa tomentosa, Compositeae, which has been used by Mexican women to prepare "tea" to induce menses and labor. Isoln and structure: M. P. Wachter, R. M. Kanojia, US 4086358 (1978 to Ortho); S. D. Levine et al., J. Am. Chem. Soc. 101, 3404 (1979); R. M. Kanojia et al., J. Org. Chem. 47, 1310 (1982). Spasmogenic effects: J. B. Smith et al., Life Sci. 28, 2743 (1981). Total syntheses of (±)-form: R. Chen, D. A. Rowand, J. Am. Chem. Soc. 102, 6609 (1980); K. C. Nicolau et al., ibid. 6611; V. V. Kane, D. L. Doyle, Tetrahedron Lett. 22, 3027, 3031 (1981). Mass spec: C. J. Shaw, Org. Mass Spectrom. 16, 281 (1981). 13C-NMR study: M. L. Cotter, Org. Magn. Reson. 17, 14 (1981).
CAS Name: Chlorotrioxochromate(1-), hydrogen, compd with pyridine (1:1)
Additional Names: PCC
Percent Composition: C 27.86%, H 2.81%, Cl 16.45%, Cr 24.12%, N 6.50%, O 22.27%
Literature References: Oxidizing agent for the efficient conversion of primary or secondary alcohols to carbonyl compounds. Prepn: R. J. Meyer, H. Best, Z. Anorg. Allg. Chem. 22, 192 (1899); J. Bernard, M. Camelot, C.R. Hebd. Seances Acad. Sci. 258, 5881 (1964); and use as an oxidant: E. J. Corey, J. W. Suggs, Tetrahedron Lett. 1975, 2647. Improved prepn: S. Agarwal et al., Tetrahedron 46, 4417 (1990). Oxidation, ring enlargement of furans to pyranones: G. Piancatelli et al., Tetrahedron Lett. 1977, 2199; oxidation of tertiary allylic alcohols: W. G. Dauben, D. M. Michno, J. Org. Chem. 42, 682 (1977). Role in oxidative cationic cyclization: E. J. Corey, D. L. Boger, Tetrahedron Lett. 1978, 2461. Review: G. Piancatelli et al., Synthesis 1982, 245-258.
CAS Name: (PB-7-34-1222'2')-(Hexamethylphosphoric triamide-kO)oxodiperoxy(pyridine)molybdenum
Additional Names: oxodiperoxymolybdenum(pyridine)(hexamethylphosphoric triamide); MoOPH
Percent ...
Literature References: Oxidizing agent. Prepn and structural characterization: H. Mimoun et al., Bull. Soc. Chim. Fr. 1969, 1481. Prepn and synthetic use in hydroxylation of enolates: E. Vedejs, J. Am. Chem. Soc. 96, 5944 (1974); idem et al., J. Org. Chem. 43, 188 (1978); E. Vedejs, S. Larsen, Org. Synth. 64, 127 (1986). Improved prepn: A. R. Daniewski, W. Wojciechowska, Synth. Commun. 16, 535 (1986). Synthetic applications: K. Krohn et al., Ber. 123, 1729 (1990); K. Makino et al., Tetrahedron 58, 9737 (2002). Brief review: D. B. Weibel, Synlett 2000, 1076.
CAS Name: Nitric acid thallium (3+) salt
Additional Names: thallium(III) nitrate
Percent Composition: Tl 52.35%, N 10.76%, O 36.88%
Literature References: Oxidizing reagent. Prepn and use for olefin rearrangement: A. McKillop et al., Tetrahedron Lett. 1970, 5275. Review of early uses: idem, E. C. Taylor, Endeavour 35, 88-93 (1976). Phenolic oxidation for isodityrosine functionality: K. Nakamura et al., Tetrahedron Lett. 42, 6311 (2001); promotion of ring contractions for indans: H. M. C. Ferraz et al., Tetrahedron 57, 1709 (2001). Review: idem et al., Synthesis 1999, 2001-2023; T. O. Vieira, Synlett 2002, 1017-1018.
Additional Names: (-)-Paraherquamide; [1'R-(1'a,5'ab,7'b,8'ab,9'ab)]-2',3',8'a,9'-tetrahydro-1'-hydroxy-1',4,4,8',8',11'-hexamethylspiro[4H,8H-[1,4]dioxepino[2,3-g]indole-8,7'(8'H)-[5H,6H-5a,9a](i...
Literature References: Oxindole alkaloid fungal metabolite. Isolation from Penicillium paraherquei and structure: M. Yamazaki et al., Maikotokishin 10, 27 (1980), C.A. 95, 19321p (1981); M. Yamazaki et al., Tetrahedron Lett. 22, 135 (1981); from P. charlesii and nematocidal activity: J. G. Ondeyka et al., J. Antibiot. 43, 1375 (1990). Absolute stereochemistry: T. A. Blizzard et al., J. Org. Chem. 54, 2657 (1989). Approach to synthesis: R. M. Williams, T. D. Cushing, Tetrahedron Lett. 31, 6325 (1990). Anthelmintic activity in sheep: W. L. Shoop et al., J. Parasitol. 76, 349 (1990); in dogs: W. L. Shoop et al., Vet. Parasitol. 40, 339 (1991). Toxicity: eidem, Am. J. Vet. Res. 53, 2032 (1992). Mode of action: J. M. Schaeffer et al., Biochem. Pharmacol. 43, 679 (1992).
CAS Name: N-(4-Fluorophenyl)-N-(1-methylethyl)-2-[[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]oxy]acetamide
Additional Names: N-isopropyl-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)-(4'-fluorooxya...
Literature References: Oxyacetamide herbicide. Prepn: H. Förster et al., DE 3821600; eidem, US 4968342 (1989, 1990 both to Bayer). Ecotoxicological profile: T. Hall, Pflanzenschutz-Nachr. Bayer (Engl. Ed.) 50, 187 (1997). Series of articles on chemical and biological properties, determn and field trials: ibid. 105-236. Review of properties and grass control in crops: R. Deege et al., Brighton Crop Prot. Conf. - Weeds 1995, 43.
CAS Name: N-(2-Hydroxyethyl)-2-nitro-1H-imidazole-1-acetamideTrademarks: Radinyl (Roberts)
Percent Composition: C 39.25%, H 4.71%, N 26.16%, O 29.88%
Literature References: Oxygen-mimetic which renders hypoxic cells sensitive to chemo- and radiotherapy. Prepn: A. G. Beaman et al., Antimicrob. Agents Chemother. 1967, 520. See also: W. W. Lee et al., US 4371540 (1983 to U.S. Sec'y Health Human Serv.). Pharmacology: J. M. Brown et al., Int. J. Radiat. Oncol. Biol. Phys. 7, 695 (1981). HPLC determn in biological materials: R. Ward, P. Workman, J. Chromatogr. 420, 223 (1987). Clinical pharmacokinetics and efficacy in radiation therapy: T. H. Wasserman et al., Radiother. Oncol. 20, Suppl. 1, 129 (1991). Evaluation in combination with alkylating agents: L. N. Shulman et al., Int. J. Radiat. Oncol. Biol. Phys. 29, 545 (1994).
CAS Name: N-Phenylacetamide
Additional Names: antifebrin; acetylaniline; acetylaminobenzene
Percent Composition: C 71.09%, H 6.71%, N 10.36%, O 11.84%
Literature References: p-Aminophenol deriv related to acetaminophen, q.v., with analgesic and antipyretic properties. Usually prepd from aniline and acetic acids: A. I. Vogel, Practical Organic Chemistry (London, 3rd ed., 1959) p 577. From aniline and acetyl chloride: Gattermann-Wieland, Praxis des Organischen Chemikers (Berlin, 40th ed., 1961) p 114. From aniline, acetone and ketene: Hurd, Org. Synth. coll. vol. I (New York, 2nd ed., 1941) p 332. Chemistry: G. C. Derick, J. H. Bornman, J. Am. Chem. Soc. 35, 1269 (1913). Toxicity data: P. K. Smith, W. E. Hambourger, J. Pharmacol. Exp. Ther. 54, (1935). Monograph: Gross, Acetanilid (Hillhouse Press, New Haven, 1946).
CAS Name: N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester
Additional Names: N-formyl-L-leucine ester with (3S,4S)-3-hexyl-4-[(2S)-2-hydroxytridecyl]-2-oxetanon...
Literature References: Pancreatic lipase inhibitor. Isoln from fermentation broth of Streptomyces toxytricini: P. Hadvary et al., EP 129748; eidem, US 4598089 (1985, 1986 both to Hoffmann-LaRoche). Structural elucidation: E. Hochuli et al., J. Antibiot. 40, 1086 (1987). Synthesis and absolute configuration: P. Barbier, F. Schneider, Helv. Chim. Acta 70, 196 (1987). Total synthesis: S. Hanessian et al., J. Org. Chem. 58, 7768 (1993). Mechanism of action: B. Borgström, Biochim. Biophys. Acta 962, 308 (1988). Clinical pharmacology: J. B. Hauptman et al., Am. J. Clin. Nutr. 55, 309S (1992). Clinical trial: M. H. Davidson et al., J. Am. Med. Assoc. 281, 235 (1999). Review of pharmacology and clinical efficacy in treatment of obesity: W. McNeely, P. Benfield, Drugs 56, 241-249 (1998). Evaluation of long-term efficacy and tolerability: J. Hauptman et al., Arch. Fam. Med. 9, 160 (2000).
即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.
试运营阶段,所有广告业务5折优惠
